SeaSpine launches Ventura NanoMetalene interbody device


SeaSpine has launched the Ventura NanoMetalene transforaminal intervertebral body fusion device.

Ventura NanoMetalene, which is commercially available and has been successfully implanted, is indicated for use as an adjunct to fusion in patients with degenerative disc disease (DDD). It is the latest device to leverage SeaSpine’s proprietary NanoMetalene technology, building on the surgical success of the company’s Hollywood NanoMetalene interbody device.

NanoMetalene is an “ultra-thin” layer of commercially pure titanium molecularly bonded to a PEEK-OPTIMA implant. It is applied in a proprietary high-energy, low-temperature surface process and encompasses the entire implant, including the centre graft window. SeaSpine says that this creates a 62% increase in surface area for potential titanium and bone interaction compared to the same implant with coated endplates only.

A company press release suggests that NanoMetalene offers the “uncompromised benefits” associated with traditional PEEK-OPTIMA devices such as a modulus of elasticity similar to bone and does not impair postoperative imaging, allowing surgeons to view the operative area and determine the extent of fusion of the vertebral bodies. The thin layer of NanoMetalene upholds the similar mechanical profile of its PEEK-OPTIMA core.

“We collaborated with our surgeon partners to create an implant that utilises existing instrumentation and addresses today’s increasingly complex spinal surgery requirements,” said Keith Valentine, chief executive officer of SeaSpine. “NanoMetalene technology is a great bridge product in our portfolio because it offers the benefits of hardware with biologic-driven features that support bone growth. Its success to date supports our plan to develop additional implants leveraging NanoMetalene technology in the future.”

With convex surfaces and multiple footprints, surgeons can create a secure anatomical fit, and Ventura NanoMetalene’s large graft aperture for autogenous bone graft assists in fusion, the company says. Ventura NanoMetalene is optimal for either open or minimally transforaminal lumbar intervertebral fusion procedures.

SeaSpine has received US Food and Drug Administation 510(k) clearance for a number of other NanoMetalene coated PEEK interbody devices in its current portfolio and expects to launch these additional products in future periods.